Multiple Switches From the Originator Infliximab to Biosimilars Is Effective and Safe in Inflammatory Bowel Disease: A Prospective Multicenter Cohort Study

por Hanzel, Jurij, Jansen, Jeroen M, ter Steege, Rinze W F, Gecse, Krisztina B, D’Haens, Geert R
Publicado 2021

A Combined Set of Four Serum Inflammatory Biomarkers Reliably Predicts Endoscopic Disease Activity in Inflammatory Bowel Disease

por Bourgonje, Arno R., von Martels, Julius Z. H., Gabriëls, Ruben Y., Blokzijl, Tjasso, Buist-Homan, Manon, Heegsma, Janette, Jansen, Bernadien H., van Dullemen, Hendrik M., Festen, Eleonora A. M., ter Steege, Rinze W. F., Visschedijk, Marijn C., Weersma, Rinse K., de Vos, Paul, Faber, Klaas Nico, Dijkstra, Gerard
Publicado 2019

Anemia and Iron Deficiency in Outpatients with Inflammatory Bowel Disease: Ubiquitous Yet Suboptimally Managed

por Loveikyte, Roberta, Boer, Menno, van der Meulen, Catharina N., ter Steege, Rinze W. F., Tack, Greetje, Kuyvenhoven, Johan, Jharap, Bindia, Vu, My K., Vogelaar, Lauran, West, Rachel L., van der Marel, Sander, Römkens, Tessa E. H., Mujagic, Zlatan, Hoentjen, Frank, van Bodegraven, Adriaan A., van Schaik, Fiona D. M., de Vries, Annemarie C., Dijkstra, Gerard, van der Meulen-de Jong, Andrea E.
Publicado 2022